The aim of the study was to determine unfavourable prognostic factors for patients with stomach adenocarcinoma after their surgical treatment through evaluation of prognostic indicators for cellular ploidy and proliferative activity. Material and methods. A group of 51 patients following surgical treatment due to stomach adenocarcinoma and discharged from our hospital between 1995-2000 were studied here. The material examined was encased in paraffin blocks. After histopathological verification, the tumour segments within these blocks were used for cytofluorometric analysis of DNA-ploidy according to Hedley's method. Results. In 41 (80.4%) stomach cancer patients (out of the total group of 51 patients), diploid tumours were found. No significant relationship between DNA ploidy and sex, age, symptoms, inherited susceptibility to a disease, tumour magnitude, grade of histological malignancy, or grade of clinical progression was observed. Generally, after the stomach cancer operation, the probability of five-year survival was 22.1% for patients with diploid tumours (DI=1.0), and 20% for the patients with aneuploid tumours (DI ¹ 1.0). The probability of 10-year survival was 19.2% for diploid tumours, and 10% for aneuploid tumours. These differences were not statistically significant (p=0.255). Conclusions. 1. Classical clinicopathologic factors are still the best prognostic criteria for the evaluation of long-term results of surgical treatment for stomach cancer patients. 2. Determination of DNAploidy and proliferative activity of stomach cancer did not decrease the gap between long-term results prognosis for surgical treatment and actual results.
Radical operation together with possible adjuvant therapy depending on the grade of neoplastic lesions gives patients with stomach cancer a better chance for recovery (1, 2) . However, the long-term results of such treatment are still unsatisfactory (3) .
As the evaluation of clinicopathologic criteria are often subjective and limited, the data for prognosis are not objective and surgical treatment of these patients with stomach cancer is typically unsuccessful, making it necessary to search for other unknown factors required to identify patients with a high risk of recurrence.
The purpose of the present study was as follows: -to identify unfavourable prognostic factors in patients with stomach adenocarcinoma following surgical treatment, -to evaluate the prognostic value of cellular ploidy and proliferative activity of stomach adenocarcinoma for these patients.
MATERIAL AND METHODS
A group of 51 patients following surgical treatment for to stomach adenocarcinoma were discharged from our hospital in the years 1995 -2000 and were studied here. Those patients made up almost 94% of all patients operated on over that time.
All data on patient selection for the operation, the operation procedure, operative evaluation of stomach cancer progression and the treatment immediately after operation were obtained from the Surgical Outpatient Clinic's archive of documentation. Diagnostic procedures included gastrofiberoscopy and abdominal ultrasonography in every patient and abdominal computer tomography in most patients. In six patients (11.8%), contrast barium passage of the upper section was performed. Moreover, chest X-rays in the anteroposterior and lateral projections, and electrocardiographic examination, were made in every patient. Before the planned operation, a histopathologic diagnosis was attempted, which was achievable in 49 (96.1%) stomach cancer patients.
Retrospectively, based on the operation protocols and histopathologic examination results from the resected primary tumour, lymph nodes and clear margins, as well as remote lesions and the progression grade of the disease were verified.
After discharge from the Department, information about the patients, including their postoperative treatment, was obtained from the archival documentation in the Surgical Outpatient Clinic. During the first five years, the patients were examined at least four times a year (every three months), and after that, every six months. To confirm the date of a possible death of a patient, the information obtained was verified in the Regional Unit of National Register Department of Communication and Information of Ministry of Home Affairs in Katowice, and in the Centre of Analyses and Medical Statistics of Silesian Public Health Centre in Katowice.
Histopathologic analysis
Clinical specimens for examination were received from paraffin blocks of tumour segments from 51 stomach cancer patients that had undergone surgical treatment for their neoplasia. The paraffin blocks were cut into microtome sections, each approximately 5 µm thick, and stained with hematoxylin and eosin. Every histological specimen was examined by two independent pathomorphologists. They confirmed the diagnosis of stomach adenocarcinoma in every patient and determined a grade of histological malignancy (G).
Preparation of the material for cytofluorometric analysis
After histopathological verification, the tumour segments received in paraffin blocks were used for cytofluorometric analysis of DNA-ploidy. All cytofluorometric examinations were performed in the Department of Neoplasm Pathology of Cracow Branch of Oncology Centre.
To prepare cellular nuclei suspensions from paraffin-embedded tissues, the modified method described by Hedley et al. was applied (4).
In two or three paraffin sections of 50 µm thickness each, the paraffin was removed with xylene. The sections were also dehydrated in a series of alcohols of decreasing concentration, followed by etching in a 0.5% solution of pepsin (pH=1.5) at 37°C for one hour. A centrifuged suspension of cellular nuclei was incubated with propidium iodide (PI, Calbiochem) and then with ribonuclease (RNA -Sigma).
Stained specimens were measured up to two hours after finishing the preparation. The specimens were collected and analyzed in a flow cytometer (FACSCalibur, Becton-Dickinson) with an argon laser of 15 mW and an inducing light wavelength equal to 488 nm.
At least 10 000 cellular nuclei were analyzed each time. Ploidy and proliferation were performed by the ModFit program. Classification of DNA histograms in relation to ploidy was based on the criteria recommended by Shankey et al. (DNA Cytometry Consensus Conference from 1992) (5).
Histograms were described to be diploid when only one fluorescence signal was observed and corresponding to G0/G1-phase cells. Any additional fluorescence signals or percentage of G2/M-phase cells above 20% qualified the histograms to be aneuploid. Aneuploidy degree was presented as the DNA index (DI), i.e. ratio of fluorescence intensity for G0/G1-phase cells of abnormal population to fluorescence intensity for G0/G1-phase cells of the normal cell population. For the diploid population, DI=1.0.
A diploid histogram of CV (coefficient variance) value (width of fluorescence signal for G0/G1-phase normal cell population within the half of its height) above 8% was determined to be useless for interpretation. For aneuploid histograms, the percentage of S-phase cells was given only for the aneuploid population. The proliferation index (PI) was a sum of percentages of S-, G2-, and M-phase cells.
Methods of statistical analysis
The data were collected in an Excel XP 2002 (Microsoft, Redmond, WA, USA). After preliminary verification, the data were transferred to the database in STATISTICA 6.0 PL. Then the distribution was determined by Kolmogorov-Smirnov's test to compare normal distribution values, followed by the Student's t-test, while for the variables of other distribution than normal, the U Mann-Whitney's test was used.
Sizes in the groups under study were compared by chi-square test. In the survival analysis, the Kaplan-Meyer method was used, and F Cox's test was applied to compare survival curves in the groups under study. Death risk due to the factors under study was determined by a method of Cox's proportional hazard regression. The results are presented in the form of means, standard deviations, absolute sizes, percentages, and by Kaplan-Meyer analysis for the cumulative proportion of survivors. p<0.05 was assumed as significant.
RESULTS
In 41 (80.4%) stomach cancer patients (from the total group of 51 patients), diploid tumours were found. In 18 patients (35.3%), late metastases were found as well. Eight patients had single metastases (5x) and multiple metastases (3x) in the liver. Five patients had pulmonary metastases and other two patientsto lymph nodes in retroperitoneal space. Other data are presented in tab. 1.
At the beginning of hospitalization, 47 (92.0%) patients reported different troubling symptoms. Most often they had abdominal pain (92.2%) and body mass loss (90.2%), and less often they reported weakness (54.9%), diarrhea (27.5%), constipation (19.6%) and bloody stool (13.7%).
A relationship between cellular ploidy and different clinicopathologic factors in the group of patients with stomach cancer is presented in tab. 2. As it can be seen from the table, no significant relationship between DNA ploidy and sex, age, symptoms, inherited susceptibility to a disease, tumour magnitude, grade of histological malignancy, or grade of clinical progression was observed.
The average percentage of S-phase cells in stomach cancer was 9±10.5%. Aneuploid tumours had a higher percentage of S-phase cells than diploid carcinomas (18.49±19.35 vs 6.70±5.13; p<0.001).
Generally, after surgical treatment due to stomach cancer, the probability of five-year survival was 21.6%, while 10-year survival was 13.3%.
Compared to women, men had a significantly better prognosis (p=0.029). For men, the probability of five-year survival was 30%, and ten-year survival was 20%. For women, the same probability was 14.3%. The age of the patients operated on for stomach cancer did not effect the probability of their survival (p=0.339).
The lack of symptoms had a significant effect on the prognosis for stomach cancer patients. The probability of five-year survival was 71.4%, 10-year survival was 37.7%, and were definitely lower, 35.1% and 18.7%, respectively, for the patients who complained of different symptoms (p<0.024) ( fig. 1 ). Significant differences in survival probability in relation to tumour magnitude were found (p=0.032) ( fig. 2 ). When the tumour was up to 5 cm in size, the probability of five-year survival was 37.5%, and 10-year survival was 25%. When the tumour was over 5 cm, the probability was 17.1% and 14.3% after five and 10 years, respectively.
However, no statistically significant differences (p=0.076) in the patients' survival were observed between the groups with lower (T1+T2) and higher (T3+T4) grade of T marker progression.
In the group of patients without metastases to regional lymph nodes, the probability of five-year survival was 60%, and 10-year survival was 46.7%. However, in the case of metastases to regional lymph nodes, the probability was 8.3% and 5.6%, respectively (p<0.001) ( fig. 3) .
When late metastases were found at the same time as primary tumour, the probability of survival was definitely low (p=0.007). For patients who had late metastases following their operation, the probability of five-and 10-year survival was 11.1%, in comparison to 30.3% and 21.2%, respectively, for the patients without metastases (fig. 4) .
Grade of histological malignancy (G) of stomach cancers (p<0.001) ( fig. 5 ) had a significant effect on differences in the patients' survival probabilities. When the grade of mali- Fig. 3 . Effect of metastases in regional lymph nodes on long-term results for surgical treatment of patients with stomach adenocarcinoma gnancy (G1) was low, the probability of fiveyear survival was 87.5%, and 10-year survival was 75%, while in the case of a higher grade of histological malignancy (G2+G3) the probabilities were 11.6% and 7%, respectively. Generally, after the operation, the probability of five-year survival was 22.1% for the patients with diploid tumours (DI=1.0), and 20% for those patients with aneuploid tumours (DI¹1.0). The probability of 10-year survival was 19.2% for diploid tumours, and 10% for aneuploid tumors. These differences were not statistically significant (p=0.255) (fig. 6) .
A comparison of the patients' survival probability, while taking a median of S-phase cells percentage as a boundary value, did not show any statistically significant differences, either (p=0.256) ( fig. 7) . The probability of five-and 10-year survival was 26.9% and 23.1%, respectively, if the percentage of S-phase cells was lower than 6.6%, and 20%, and 12%, respectively, when this value was equal or higher.
Multivariate analysis
Multivariate analysis of total survival time of stomach cancer patients, after considering all factors effecting patients' survival, suggests that independent unfavorable prognostic features are as follows (tab. 3): -size of primary tumour (p=0.013), -metastases to regional lymph nodes (p=0.016), -operations on female (p=0.009), -high grade of histological malignancy (G) (p=0.008).
DISCUSSION
It would appear that the extent of malignant disease and the possibility of a radical operation are the most important prognostic features for evaluating long-term results of surgical treatment for stomach adenocarcinomas (2, 6) . However, cancer may develop for many years before it is clinically diagnosed and may cause micrometastases. Thus, stomach cancer is, in fact, a systematic disease at the moment of diagnosis and surgical treatment does not make long-term results any better (7). This is the reason why a cellular ploidy pattern determined by flow cytofluorometry (FCM) and a grade of carcinoma proliferation (SPF or IP) may be helpful in supplementing clinicopathologic factor evaluation (8) (9) (10) (11) (12) . It can also help in the study of cytostatic resistance of neoplasms, tumour invasiveness and potential to give metastases (13) .
Many studies show a correlation between cellular ploidy pattern and late results in stomach cancer patients' treatment (3, 6, 7, 8, 14) . Some authors even conclude that aneuploidy is an independent unfavorable prognostic factor (15, 16) .
Yonemura (17), after analysis of 493 paraffin-embedded segments, concluded that aneuploidy correlates with various factors effecting faster development of a tumour, such as serosa infiltration and metastases to lymph nodes, peritoneum space, and liver. However, other authors, and the results of our studies as well, do not confirm these relationships (2).
Lee, Sasaki and Bazan showed a correlation between more frequent aneuploidy and higher grade of histological malignancy in the group of stomach cancer (3, 18, 19) . However, our results do not confirm this correlation and are in agreement with the results presented by Ballantyne and Esteban (15, 20) .
Such differences and controversies in the results of these studies may be caused by technical and biological study conditions, caused in turn by differences in tumour character (21) . It may refer to patient population size, patient selection for the study, types of segments being isolated, methods of destruction of the tissue to be examined, method of data analysis, and heterogeneity of the neoplasm DNA (22) .
In the group of 51 stomach adenocarcinomas, 19.6% of neoplasms had an aneuploid pattern, which is lower than what has been reported in the literature (25-71%). However, this might be caused by a non-advanced stage, because in 63% of patients at the moment of operation the grade was T1 or T2, and in 72.5% no metastases to regional lymph nodes were found (29.4%) or only N1 were found (43.1%). In addition, the method and location of the segments that were isolated may be another reason.
A similar opinion is presented by Kim and Hirose, who observed a directly proportional relationship between frequency of recognized aneuploidy and grade of clinicopathologic progression of stomach cancer (8, 23) . However, Mizunana, Lee and Estaban did not confirm these observations (11, 15, 16) . In the studies by Nanus and Johnosos Jr. (2, 24) , frequency of aneuploidy in the tumours located around the cardia was higher than in the tumours located near the stomach body and pylorus (95% vs. 20%). Yet, Lee (3) did not confirm this relation. However, he proved a statistically significant higher frequency of aneuploidy in stomach cancer of the intestinal type (70%) compared to diffuse type (40%).
Kim (8) did not observe any relation between DNA ploidy pattern and metastases to regional lymph nodes. Yet, Yonemura (17) described more frequent metastases to regional lymph nodes in the patients with aneuploid cancers. Similar conclusions have been presented by others (9, 10, 12) . Our results do not confirm these observations. Imada (25) suggests that there are two reasons why the correlation between cellular ploidy pattern, clinicopathologic factors and remote results of treatment may be different. The first reason is that the tissue is prepared for examination in different ways, which is connected (like in the case of all solid tumours) with the material for examination (fresh, frozen, or formalin-or paraffin-embedded). In DNA analysis of paraffin sections, a coefficient of variance (CV) is often much higher, contrary to fresh material. It can make the studies based on the material coming from a paraffin block difficult to properly interpret, because a single aneuploid peak G0/G1 may be determined as diploid.
DNA heterogeneity of the tumours, described in the range of 40-60% of gastrointestinal cancers, may be another reason (12, 26, 27) . Differences in DNA within the same neoplasm can be observed in a wide range from 5% to 49% of solid tumours (25, 28) . It can be frequently observed that various types of cells with regard to DNA ploidy pattern may co-exist within one tumour. Due to such heterogeneity, the cellular ploidy pattern seems to be dependent on the sampling position within the tumour. Some authors claim that DNA analysis from one segment only is not sufficient (1, 27) .
It seems obvious that depth of invasion is one of the most important prognostic features in the patients operated due to stomach cancer (8) . Segments isolated from the surface and inside of stomach tumours had different cellular ploidy. The differences were observed in 31.8% of tumours. More than half (16/28) of the isolated segments from the tumour surface had a diploid pattern, and, inversely, segments from inside of the tumour were mostly in an aneuploid pattern (25) .
Haraguchi (28) described that metastases to regional lymph nodes and peritoneum space occurred more often in patients with heterogenic neoplasm in relation to cellular ploidy pattern. This phenomenon is an important unfavorable prognostic feature. Matsumoto (26) showed that for patients with tumour heterogeneity, five-year survival is different than for the patients with diploid or aneuploid tumours. The studies showed that the patients with aneuploidy in both segments (from surface and inside) lived shorter than the ones with diploidy. Survival of the patients with heterogenic tumours was close to late results of the patients with diploid segments. Yet, differences in survival were not statistically significant. It is suggested that cellular ploidy can be an important prognostic feature, but for less advanced neoplasms.
This may be the reason why the long-term results of treatment when considering cellular ploidy as a prognostic feature are controversial and differentiated; as this is also reflected in our studies.
Lee (3) showed that in stomach cancer, the percentage of S-phase cells and the grade of TNM progression were the most important
